Publication:
Serum and Urine Galectin-9, IP-10 and SIGLEC-1 as Biomarkers of Disease Activity in Patients with Systemic Lupus Erythematosus Compared to ANCA-Associated Vasculitis: A Longitudinal Study

Simple item page
dc.contributor.authorMirioğlu, Şafak
dc.contributor.authorÇınar, Suzan
dc.contributor.authorUludağ, Ömer
dc.contributor.authorGürel, Erdem
dc.contributor.authorVarelci, Sibel
dc.contributor.authorÖzlük, Mesude Yasemin
dc.contributor.authorKılıçaslan, Işın
dc.contributor.authorYalçınkaya, Yasemin
dc.contributor.authorYazıcı, Halil
dc.contributor.authorGül, Ahmet
dc.contributor.authorİnanç, Murat
dc.contributor.authorArtım Esen, Bahar
dc.contributor.institutionauthorMİRİOĞLU, ŞAFAK
dc.date.accessioned2022-05-08T20:59:14Z
dc.date.available2022-05-08T20:59:14Z
dc.date.issued2022-05-03T00:00:00Z
dc.identifier.doi10.1093/ndt/gfac110.003
dc.identifier.urihttp://hdl.handle.net/20.500.12645/30579
dc.subjectMirioğlu Ş., Çınar S., Uludağ Ö., Gürel E., Varelci S., Özlük M. Y. , Kılıçaslan I., Yalçınkaya Y., Yazıcı H., Gül A., et al., -Serum and Urine Galectin-9, IP-10 and SIGLEC-1 as Biomarkers of Disease Activity in Patients with Systemic Lupus Erythematosus Compared to ANCA-Associated Vasculitis: A Longitudinal Study-, 59th ERA Congress, Paris, Fransa, 19 - 22 Mayıs 2022, cilt.37, ss.830-831
dc.titleSerum and Urine Galectin-9, IP-10 and SIGLEC-1 as Biomarkers of Disease Activity in Patients with Systemic Lupus Erythematosus Compared to ANCA-Associated Vasculitis: A Longitudinal Study
dc.typeConference Paper
dspace.entity.typePublication
local.avesis.id91b5b6ee-132f-4b30-ba32-ca63e40bcc10
local.publication.isinternational1
relation.isAuthorOfPublication1a6fde04-64ba-4074-8a18-b696ffbbbd3e
relation.isAuthorOfPublication.latestForDiscovery1a6fde04-64ba-4074-8a18-b696ffbbbd3e

Files

Collections

Yayınlar - Eserler